The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2019

Filed:

Dec. 18, 2017
Applicant:

United States of America As Represented BY Secretary of Agriculture, Washington, DC (US);

Inventors:

Richard Mauldin, Loveland, CO (US);

Doug Eckery, Fort Collins, CO (US);

Lowell Miller, Greeley, CO (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/04 (2006.01); A61K 39/00 (2006.01); A61K 35/74 (2015.01); A61P 15/18 (2006.01); A61P 15/16 (2006.01); A61K 39/39 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/0006 (2013.01); A61K 39/04 (2013.01); A61P 15/16 (2018.01); A61P 15/18 (2018.01); A61K 35/74 (2013.01); A61K 2039/54 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55594 (2013.01); A61K 2039/6068 (2013.01);
Abstract

A vaccine adjuvant and immunogenic composition may be described herein. The vaccine adjuvant may comprise cell wall fragments of the genus, and more particularly, of. The immunogenic composition may include the vaccine adjuvant conjugated to an antigen. For example, cell wall fragments of(herein also referred to as MAF) may be conjugated to an antigen targeting Gonadotropin releasing hormone (GnRH). The MAF-antigen conjugate may be delivered for the purposes of treatment through one of several methods, including intramuscular injection, naso-pharyngeal, or oral.


Find Patent Forward Citations

Loading…